Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 283-289

  Qu, Zhonghua ^a   Liang, Xiaohong ^a   Liu, Yugang ^a   Du, Juan ^b   Liu, Suxia ^a   Sun, Wensheng ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Blockade; CD59; Complement; Cytotoxicity; Hepatitis B virus

Indexed keywords

CD59 ANTIGEN; COMPLEMENT REGULATOR PROTEIN; MESSENGER RNA; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; TRANSGENIC MOUSE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD59; CELL LINE, TUMOR; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; LIVER; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; TRANSFECTION;

HEPATITIS B VIRUS; MUS;

EID: 70450224086     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.022     Document Type: Article

References (29)

1. Baalasubramanian S., Harris C.L., Donev R.M., Mizuno M., Omidvar N., Song W.C., and Morgan B.P. CD59a is the primary regulator of membrane attack complex assembly in the mouse. J. Immunol. 173 (2004) 3684-3692
2. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2 (1981) 1129-1133
3. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
4. Bertoletti A., and Ferrari C. Kinetics of the Immune response during HBV and HCV infection. Hepatology 38 (2003) 4-13
5. Bodian D.L., Davis S.J., Morgan B.P., and Rushmere N.K. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J. Exp. Med. 185 (1997) 507-516
6. Davies A., Simmon L., Hale G., Harrison R.A., Tighe H., Lachmann P.J., and Waldmann H. CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170 (1989) 637-654
7. Donev R.M., Cole D.S., Sivasankar B., Hughes T.R., and Morgan B.P. p53 regulates cellular resistance to complement lysis through enhanced expression of CD59. Cancer Res. 66 (2006) 2451-2458
8. Donev R.M., Sivasankar B., Mizuno M., and Morgan B.P. The mouse complement regulator CD59b is significantly expressed only in testis and plays roles in sperm acrosome activation and motility. Mol. Immunol. 45 (2008) 534-542
9. Dunn C., Brunetto M., Reynolds G., Christophides T., Kennedy P.T., Lampertico P., Das A., Lopes A.R., Borrow P., Williams K., Humphreys E., Afford S., Adams D.H., Bertoletti A., and Maini M.K. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204 (2007) 667-680
10. Guidotti L.G., and Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1 (2006) 23-61
11. Halme J., Sachse M., Vogel H., Giese T., Klar E., and Kirschfink M. Primary human hepatocytes are protected against complement by multiple regulators. Mol. Immunol. 46 (2009) 2284-2289
12. Liang X., Liu Y., Zhang Q., Gao L., Han L., Ma C., Zhang L., Chen Y.H., and Sun W. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J. Immunol. 178 (2007) 503-510
13. Mehlhop E., and Diamond M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203 (2006) 1371-1381
14. Morgan B.P. Regulation of the complement membrane attack pathway. Crit. Rev. Immunol. 19 (1999) 173-198
15. Morgan B.P., and Harris C.L. Complement therapeutics; history and current progress. Mol. Immunol. 40 (2003) 159-170
16. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., and O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28 (1998) 84-90
17. Omidvar N., Wang E.C., Brennan P., Longhi M.P., Smith R.A., and Morgan B.P. Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity. J. Immunol. 176 (2006) 2915-2923
18. Qian Y.M., Qin X., Miwa T., Sun X., Halperin J.A., and Song W.C. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. J. Immunol. 165 (2000) 2528-2534
19. Qin X., and Gao B. The complement system in liver diseases. Cell. Mol. Immunol. 3 (2006) 333-340
20. Qu J., Lin J., Zhang S., Zhu Z., Ni C., Zhang S., Gao H., and Zhu M. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells. Biochem. Biophys. Res. Commun. 386 (2009) 504-509
21. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5 (2005) 215-229
22. Santoro F., Kennedy P.E., Locatelli G., Malnati M.S., Berger E.A., and Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 99 (1999) 817-827
23. Speth C., Stoiber H., and Dierich M.P. Complement in different stages of HIV infection and pathogenesis. Int. Arch. Allergy Immunol. 130 (2003) 247-257
24. Spiller O.B., Morgan B.P., Tufaro F., and Devine D.V. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur. J. Immunol. 26 (1996) 1532-1538
25. Steel L.F., Shumpert D., Trotter M., Seeholzer S.H., Evans A.A., London W.T., Dwek R., and Block T.M. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3 (2003) 601-609
26. Takemoto M., Yamanishi K., and Mori Y. Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. J. Gen. Virol. 88 (2007) 1415-1422
27. Vasei M., Monabbati A., Alizadeh-Naeeni M., Houshmand S., Azarpira N., Lankarani K.B., Mosallaee M., Taghavi S., Geramizadeh B., Saberi-Firouzi M., and Imaniyeh M.H. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients. Hepatogastroenterology 55 (2008) 1066-1070
28. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344 (2001) 1140-1144
29. Xiong Y., Jia Y., and Wang H. High-level hepatitis B virus expression in transgenic mice. Infect. Dis. Info. 13 (2000) 164-165